SCHEMBL7028443

SCHEMBL7028443

CCc1nnc(N)n(N)c1=O

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
GAA P10253 1/20 0.31
LMNA P02545 1/20 0.30
GAK O14976 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7031307 0.98 GAA (0.33) KDM4EALDH1A1MAPTGAA
SCHEMBL7030432 0.84 ALDH1A1 (0.35) KDM4EALDH1A1MAPT
SCHEMBL11608060 0.79 LMNA (0.40) KDM4EALDH1A1MAPTGAALMNA
SCHEMBL7144640 0.79 ALDH1A1 (0.33) KDM4EALDH1A1MAPTGAA
SCHEMBL11710424 0.78 KDM4E (0.32) KDM4EALDH1A1MAPT
SCHEMBL10549684 0.76 ALDH1A1 (0.40) KDM4EALDH1A1MAPTLMNA
SCHEMBL9802011 0.75 NPSR1 (0.30)
SCHEMBL11605697 0.73 CACNA2D1 (0.31) KDM4EALDH1A1MAPT
SCHEMBL7031322 0.72 LMNA (0.46) KDM4EALDH1A1MAPTLMNA
Hydrochloric Acid SCHEMBL7030321 0.71 LMNA (0.45) KDM4EALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0889884-B1 1,2,4-TRIAZINE DERIVATIVES FOR THE INHIBITION OF PROTEIN GLYCOSYLATION ALTEON INC (US) 2003-01-29 EP claimed
EP-0889884-B1 1,2,4-TRIAZINE DERIVATIVES FOR THE INHIBITION OF PROTEIN GLYCOSYLATION ALTEON INC (US) 2003-01-29 EP disclosed
US-6380192-B1 FOR INHIBITING NONENZYMATIC CROSS-LINKING (PROTEIN AGING) ALTEON, INC. 2002-04-30 US disclosed
US-6060470-A Triazine compounds and methods of use therefor ALTEON, INC. 2000-05-09 US disclosed
US-5932578-A CAPABLE OF INHIBITING THE FORMATION OF ADVANCED GLYCOSYLATION ENDPRODUCTS OF TARGET PROTEINS. FOOD SPOILAGE AND ANIMAL PROTEIN AGING CAN BE TREATED. ALTEON INC. (US) 1999-08-03 US disclosed